-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Sell in April and Go Away?
With sell signals flashing on the midcap and small-cap indices, this may be the right course of action for lower-quality stocks.
India Drops Patent Bomb on Novartis
India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma.
FDA Approves Novel Type 2 Diabetes Drug
A new treatment for type 2 diabetes has been approved by the Food and Drug Administration.
2 Healthy Stocks for Any Portfolio
The heathcare sector has been booming lately and shows no sign of slowing down. These two sturdy stocks look poised to continue their outperformance.
Biotech Movers: Acadia Jumps, Affymax Crashes
Last week, Acadia Pharmaceuticals rode the winds of good clinical results, while news of mass layoffs sent Affymax crashing again.
The Early Investor Bird Does Catch the Worm
When I look for investment opportunities, I am drawn to some of the world's most innovative companies and these 5 biotech stocks fit the bill for investment
Make a Straightforward Play in Biotech
The iShares Nasdaq Biotechology Index Fund is a great way to get into biotechs ... just not now. It's due for a buyers' exhaustion break, so wait and keep watch.
Pounce on This Biotech Favorite If it Falls Back Into Buying Range
Celgene Corp. (NASDAQ:CELG) broke from a rectangle consolidation, forming a steep bull channel.
Humana’s Golden Cross Points to Healthy Returns for Traders
The formation was preceded by a possible selling climax and followed by a MACD buy signal.
FDA Intensifies Warning on Common ‘Z-Pak’ Antibiotic
The Food and Drug Administration is requiring tougher language in the warning labels for azithromycin, an antibiotic, after a study showed an elevelated risk.
Biotech Movers: Peregrine, PharmAthene Climb on Analyst Coverage
Last week in biotech news, Peregrine and PharmAthene both climbed on bullish analyst coverage. Also, find out why Sequenom shed double-digits in one day.
Newborn Cured of HIV
A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth.
Biotech Movers: Affymax Crashes on Recall
Last week, shares of Affymax got hammered when the company pulled back units of its sole commercial drug. Plus, find out what sent the biggest gainers skyward.
Anemia Drug Recalled After Patient Deaths
Omontys, a drug meant to treat anemia in dialysis patients, from Affymax has been recalled after a number of patients died shortly after receiving it.
Health Insurers Hit by Medicare Rates
The health insurance sector took a beating after one of the biggest names in the business warned that premium Medicare payment rates will decline next year.
Get This Blazing Hot Biotech for a Reasonable Price
A consolidation in Celgene Corp. is giving traders the perfect opportunity to buy at a bargain.
Gilead Sciences Headed for New Highs
Gilead Sciences is in an orderly bull market characterized by breakouts and breakaway gaps.
Top 10 Dow Dividend Stocks for February
Income investors could do a lot worse than buying into these venerable blue chips -- especially the stock that continues to hold the crown.
3 Healthcare Stocks About to Receive a Booster Shot
Despite the impressive performance of healthcare stocks as a whole, many aren't getting much analyst love. But these three will -- and when they do, look out!
